CN109091650A - A kind of anti-cancer drugs granule and preparation method thereof - Google Patents

A kind of anti-cancer drugs granule and preparation method thereof Download PDF

Info

Publication number
CN109091650A
CN109091650A CN201811175823.2A CN201811175823A CN109091650A CN 109091650 A CN109091650 A CN 109091650A CN 201811175823 A CN201811175823 A CN 201811175823A CN 109091650 A CN109091650 A CN 109091650A
Authority
CN
China
Prior art keywords
parts
preparation
cancer drugs
enzyme solution
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811175823.2A
Other languages
Chinese (zh)
Inventor
张玉丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui Bajin Pharmaceutical Co Ltd
Original Assignee
Anhui Bajin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui Bajin Pharmaceutical Co Ltd filed Critical Anhui Bajin Pharmaceutical Co Ltd
Priority to CN201811175823.2A priority Critical patent/CN109091650A/en
Publication of CN109091650A publication Critical patent/CN109091650A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/646Arachnids, e.g. spiders, scorpions, ticks or mites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/648Myriapods, e.g. centipedes or millipedes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233Bupleurum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634Forsythia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/748Oldenlandia or Hedyotis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/15Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Insects & Arthropods (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of preparation of anti-cancer drugs granule, include the following steps: that (1) raw material weighs;(2) pretreatment of raw material;(3) extraction is handled;(4) concentration;(5) drying and granulating.The anti-cancer drugs granule that the present invention is finally prepared, material matching is reasonable, and bioavilability is high, has the curative effect of good pre- anti-cancer and treating cancer, and materials safety, great market popularization value.

Description

A kind of anti-cancer drugs granule and preparation method thereof
Technical field
The invention belongs to Chinese materia medica preparation preparation technical fields, and in particular to a kind of anti-cancer drugs granule and its preparation side Method.
Background technique
With the continuous promotion of modern medical service level, the life and health of people also gets better protection, however cancer It is still the serious illness for being difficult to subdue, the toxic side effect of chemicotherapy can be mitigated by traditional Chinese medicine cooperation operation, chemicotherapy now, Promote patient to restore, enhance the tolerance to chemicotherapy, but is not now very significant by the effect of Chinese medicine treating cancer, and And in the preparation process of Chinese materia medica preparation, using a large amount of Chinese medicine, the content of effective component is very low in final preparation, greatly Ground causes the waste of resource.
Summary of the invention
The purpose of the present invention is being directed to existing problem, a kind of anti-cancer drugs granule and preparation method thereof is provided, The anti-cancer drugs granule finally prepared, material matching is reasonable, and bioavilability is high, has good pre- anti-cancer and treatment cancer The curative effect of disease, and materials safety, great market popularization value.
The present invention is achieved by the following technical solutions:
A kind of preparation of anti-cancer drugs granule, includes the following steps:
(1) raw material weighs:
Weigh 2 ~ 4 parts of paris polyphylla, 2 ~ 4 parts of the uncaria, 4 ~ 6 parts of Fructus Forsythiae, 4 ~ 6 parts of oldenlandia diffusa, full worm 11 ~ 13 of corresponding parts by weight Part, 4 ~ 6 parts of curcuma zedoary, 2 ~ 4 parts recklessly purple, 3 ~ 5 parts of centipede, 2 ~ 3 parts of semen momordicae it is spare;
(2) pretreatment of raw material:
A. by weighed paris polyphylla, uncaria, Fructus Forsythiae, oldenlandia diffusa, full worm, curcuma zedoary, purple Hu, centipede, semen momordicae in step (1) It putting into deep cooling type pulverizer and is crushed respectively, it is -12 ~ -8 DEG C that the temperature in pulverizer is kept when crushing, pulverization process 20 ~ After 30min, 40 meshes are crossed respectively, then carry out each herb powder after sieving to mix to obtain mixed-powder;
B. it will operate and be impregnated in the investment enzyme solution of mixed-powder obtained in a, temperature when enzyme solution impregnates in holding enzyme solution is 39 ~ 43 DEG C, after 50 ~ 60min of enzyme solution immersion treatment, filter cake and filtrate are filtered to obtain, carries out specific frequency while enzyme solution impregnates Ultrasonication;
(3) extraction is handled:
Step (1) is operated gained filter cake in b to be placed in soxhlet extraction device, step (1) is operated into filtrate and nothing obtained in b Water-ethanol carries out mixing and extracts as digestion agent to filter cake, is heated in leaching process using microwave, and microwave heating is protected Holding the temperature in digestion agent is 88 ~ 94 DEG C, filters to obtain leaching liquor after extracting 10 ~ 12 times repeatedly;
(4) concentration:
Rotary evaporation will be carried out in the leaching liquor investment Rotary Evaporators obtained after extraction processing in step (3), rotary evaporation is straight Ethanol extract is obtained after to ethyl alcohol evaporating completely;
(5) drying and granulating:
Step (4) resulting ethanol extract is placed in baking oven and is dried, after drying to moisture content is 2 ~ 3%, after drying It is pelletized in ethanol extract investment granulator.
Further, each ingredient and corresponding parts by weight in enzyme solution in the step (2) operation b are as follows: 2 ~ 3 parts of pectase, fine It ties up plain 4 ~ 5 parts of enzyme, turn 1 ~ 2 part of glycosides enzyme, 3 ~ 4 parts of nanometer iron powder, 100 ~ 120 parts of deionized water.
Further, the w/v of mixed-powder and enzyme solution is 1g:5 ~ 6mL in step (2) the operation b.
Further, the frequency of ultrasonic wave is 20 ~ 24kHz in step (2) the operation b.
Further, the volume ratio of filtrate and dehydrated alcohol is 1:3 ~ 4 in the step (3).
Further, the frequency of microwave is 12 ~ 14GHz in the step (3).
Further, the revolving speed of Rotary Evaporators is 80 ~ 90rpm in the step (4), when rotary evaporation in water-bath Temperature setting is 80 ~ 82 DEG C.
Further, temperature control when dry in the step (5) in baking oven is 60 ~ 70 DEG C.
The present invention provides a kind of preparation of anti-cancer drugs granule, selected raw material is all middle medicinal herbs, safety coefficient Height, for anti-cancer drugs preparation of the invention using Fructus Forsythiae, oldenlandia diffusa, full worm, curcuma zedoary as monarch drug in a prescription, centipede, uncaria are ministerial drug, flea Not, radix bupleuri is adjutant, and semen momordicae is to make medicine, mutual compatibility, and the anti-cancer drugs granule finally prepared is aobvious for the curative effect of cancer It writes, almost non-toxic side effect.In the preparation process of anti-cancer drugs preparation, raw material is placed in deep cooling type pulverizer carries out first Pulverization process is crushed under cryogenic conditions, can increase the fineness of crushing, increase the contact area between each raw material, and The chemical stability of active constituent in Chinese medicine can be ensured to greatest extent, guarantee drug effect, smashed powder is placed in enzyme solution In impregnated, in enzyme solution of the invention added with cellulase, pectase, turn glycosides enzyme and nanometer iron powder, it is most in Pharmaceutically active ingredient is present in the protoplast wrapped up by cell wall, and the objects such as cellulose, lignin, pectic substance and hemicellulose Matter constitutes the compact texture of plant cell wall, it is the main barrier that effective component is suggested from medicinal plant, effectively at Divide and spread during the extraction process to Extraction medium, by the obstruction of dual resistance cell wall and cytoplasm, selects pectase water Solve pectic substance and cellulose hydrolyzation cellulose etc., the objects such as pectic substance and cellulose in can degrade cytoplasm and cell wall Matter reduces the resistance to mass tranfer that mass transfer barrier dissolves out effective component, to accelerate the proposition of effective component, in addition, collocation turns glycosides Enzyme and nanometer iron powder can reach the dual purpose for effectively proposing object and the non-targeted object dissolution of control in Chinese medicine, Dissolution efficiency not only is improved, also makes the clarity of extracting solution higher, in enzyme solution processing, ultrasonic wave auxiliary is carried out, due to rubbing Wiping effect and the absorption of medium etc. make ultrasonic energy be converted into thermal energy, and fuel factor increases the temperature of effective component in Chinese medicine, increase The solubility of big effective component, improves the leaching rate of effective component.Then it is extracted repeatedly with soxhlet extraction device, further Extraction rate is improved, during extraction, using microwave heating, effect of the molecule by microwave energy, rotation can be accelerated, if point Son has certain polarity at this time, then can occur instantaneously to polarize in microwave electromagnetic field, then doing reversal movement velocity is Hundred million seconds, further the vibration and tearing and interparticle phase mutual friction and collision of generation key, can promote molecular polarity part It better contacts with and reacts, and a large amount of thermal energy can be generated, so that cell rupture, subsequent cell liquid overflows and is diffused into solvent In, there is good impetus to the bioavilability of extracting efficiency and raw material.
The present invention has the advantage that compared with prior art
The anti-cancer drugs granule that the present invention is finally prepared, material matching is reasonable, and bioavilability is high, has pre- anti-cancer well The curative effect of disease and treating cancer, and materials safety, great market popularization value.
Specific embodiment
Embodiment 1
A kind of preparation of anti-cancer drugs granule, includes the following steps:
(1) raw material weighs:
Weigh 2 parts of paris polyphylla, 2 parts of the uncaria, 4 parts of Fructus Forsythiae, 4 parts of oldenlandia diffusa, 11 parts of full worm, 4 parts of curcuma zedoary, purple of corresponding parts by weight 2 parts recklessly, 3 parts of centipede, 2 parts of semen momordicae it is spare;
(2) pretreatment of raw material:
A. by weighed paris polyphylla, uncaria, Fructus Forsythiae, oldenlandia diffusa, full worm, curcuma zedoary, purple Hu, centipede, semen momordicae in step (1) It puts into deep cooling type pulverizer and is crushed respectively, it is -12 DEG C that the temperature in pulverizer is kept when crushing, pulverization process 20min Afterwards, 40 meshes are crossed respectively, then carry out each herb powder after sieving to mix to obtain mixed-powder;
B. it will operate and be impregnated in the investment enzyme solution of mixed-powder obtained in a, temperature when enzyme solution impregnates in holding enzyme solution is 39 DEG C, after enzyme solution immersion treatment 50min, filter cake and filtrate are filtered to obtain, the ultrasound of specific frequency is carried out while enzyme solution impregnates Wave processing;
(3) extraction is handled:
Step (1) is operated gained filter cake in b to be placed in soxhlet extraction device, step (1) is operated into filtrate and nothing obtained in b Water-ethanol carries out mixing and extracts as digestion agent to filter cake, is heated in leaching process using microwave, and microwave heating is protected Holding the temperature in digestion agent is 88 DEG C, filters to obtain leaching liquor after extracting 10 times repeatedly;
(4) concentration:
Rotary evaporation will be carried out in the leaching liquor investment Rotary Evaporators obtained after extraction processing in step (3), rotary evaporation is straight Ethanol extract is obtained after to ethyl alcohol evaporating completely;
(5) drying and granulating:
Step (4) resulting ethanol extract is placed in baking oven and is dried, after drying to moisture content is 2%, by the second after drying It is pelletized in alcohol medicinal extract investment granulator.
Further, each ingredient and corresponding parts by weight in enzyme solution in the step (2) operation b are as follows: 2 ~ 3 parts of pectase, fine It ties up plain 4 parts of enzyme, turn 1 part of glycosides enzyme, 3 parts of nanometer iron powder, 100 parts of deionized water.
Further, the w/v of mixed-powder and enzyme solution is 1g:5mL in step (2) the operation b.
Further, the frequency of ultrasonic wave is 20kHz in step (2) the operation b.
Further, the volume ratio of filtrate and dehydrated alcohol is 1:3 in the step (3).
Further, the frequency of microwave is 12GHz in the step (3).
Further, the revolving speed of Rotary Evaporators is 80rpm in the step (4), temperature when rotary evaporation in water-bath Degree is set as 80 DEG C.
Further, temperature control when dry in the step (5) in baking oven is 60 DEG C.
Embodiment 2
A kind of preparation of anti-cancer drugs granule, includes the following steps:
(1) raw material weighs:
Weigh 3 parts of paris polyphylla, 3 parts of the uncaria, 5 parts of Fructus Forsythiae, 5 parts of oldenlandia diffusa, 12 parts of full worm, 5 parts of curcuma zedoary, purple of corresponding parts by weight 3 parts recklessly, 4 parts of centipede, 2.5 parts of semen momordicae it is spare;
(2) pretreatment of raw material:
A. by weighed paris polyphylla, uncaria, Fructus Forsythiae, oldenlandia diffusa, full worm, curcuma zedoary, purple Hu, centipede, semen momordicae in step (1) It puts into deep cooling type pulverizer and is crushed respectively, it is -10 DEG C that the temperature in pulverizer is kept when crushing, pulverization process 25min Afterwards, 40 meshes are crossed respectively, then carry out each herb powder after sieving to mix to obtain mixed-powder;
B. it will operate and be impregnated in the investment enzyme solution of mixed-powder obtained in a, temperature when enzyme solution impregnates in holding enzyme solution is 41 DEG C, after enzyme solution immersion treatment 55min, filter cake and filtrate are filtered to obtain, the ultrasound of specific frequency is carried out while enzyme solution impregnates Wave processing;
(3) extraction is handled:
Step (1) is operated gained filter cake in b to be placed in soxhlet extraction device, step (1) is operated into filtrate and nothing obtained in b Water-ethanol carries out mixing and extracts as digestion agent to filter cake, is heated in leaching process using microwave, and microwave heating is protected Holding the temperature in digestion agent is 91 DEG C, filters to obtain leaching liquor after extracting 11 times repeatedly;
(4) concentration:
Rotary evaporation will be carried out in the leaching liquor investment Rotary Evaporators obtained after extraction processing in step (3), rotary evaporation is straight Ethanol extract is obtained after to ethyl alcohol evaporating completely;
(5) drying and granulating:
Step (4) resulting ethanol extract is placed in baking oven and is dried, after drying to moisture content is 2.5%, after drying It is pelletized in ethanol extract investment granulator.
Further, each ingredient and corresponding parts by weight in enzyme solution in the step (2) operation b are as follows: 2.5 parts of pectase, fine It ties up plain 4.5 parts of enzyme, turn 1.5 parts of glycosides enzyme, 3.5 parts of nanometer iron powder, 110 parts of deionized water.
Further, the w/v of mixed-powder and enzyme solution is 1g:5.5mL in step (2) the operation b.
Further, the frequency of ultrasonic wave is 22kHz in step (2) the operation b.
Further, the volume ratio of filtrate and dehydrated alcohol is 1:3.5 in the step (3).
Further, the frequency of microwave is 13GHz in the step (3).
Further, the revolving speed of Rotary Evaporators is 85rpm in the step (4), temperature when rotary evaporation in water-bath Degree is set as 81 DEG C.
Further, temperature control when dry in the step (5) in baking oven is 65 DEG C.
Embodiment 3
A kind of preparation of anti-cancer drugs granule, includes the following steps:
(1) raw material weighs:
Weigh 4 parts of paris polyphylla, 4 parts of the uncaria, 6 parts of Fructus Forsythiae, 6 parts of oldenlandia diffusa, 13 parts of full worm, 6 parts of curcuma zedoary, purple of corresponding parts by weight 4 parts recklessly, 5 parts of centipede, 3 parts of semen momordicae it is spare;
(2) pretreatment of raw material:
A. by weighed paris polyphylla, uncaria, Fructus Forsythiae, oldenlandia diffusa, full worm, curcuma zedoary, purple Hu, centipede, semen momordicae in step (1) It puts into deep cooling type pulverizer and is crushed respectively, it is -8 DEG C that the temperature in pulverizer is kept when crushing, pulverization process 30min Afterwards, 40 meshes are crossed respectively, then carry out each herb powder after sieving to mix to obtain mixed-powder;
B. it will operate and be impregnated in the investment enzyme solution of mixed-powder obtained in a, temperature when enzyme solution impregnates in holding enzyme solution is 43 DEG C, after enzyme solution immersion treatment 60min, filter cake and filtrate are filtered to obtain, the ultrasound of specific frequency is carried out while enzyme solution impregnates Wave processing;
(3) extraction is handled:
Step (1) is operated gained filter cake in b to be placed in soxhlet extraction device, step (1) is operated into filtrate and nothing obtained in b Water-ethanol carries out mixing and extracts as digestion agent to filter cake, is heated in leaching process using microwave, and microwave heating is protected Holding the temperature in digestion agent is 94 DEG C, filters to obtain leaching liquor after extracting 12 times repeatedly;
(4) concentration:
Rotary evaporation will be carried out in the leaching liquor investment Rotary Evaporators obtained after extraction processing in step (3), rotary evaporation is straight Ethanol extract is obtained after to ethyl alcohol evaporating completely;
(5) drying and granulating:
Step (4) resulting ethanol extract is placed in baking oven and is dried, after drying to moisture content is 3%, by the second after drying It is pelletized in alcohol medicinal extract investment granulator.
Further, each ingredient and corresponding parts by weight in enzyme solution in the step (2) operation b are as follows: 3 parts of pectase, fiber 5 parts of plain enzyme turns 2 parts of glycosides enzyme, 4 parts of nanometer iron powder, 120 parts of deionized water.
Further, the w/v of mixed-powder and enzyme solution is 1g:6mL in step (2) the operation b.
Further, the frequency of ultrasonic wave is 24kHz in step (2) the operation b.
Further, the volume ratio of filtrate and dehydrated alcohol is 1:4 in the step (3).
Further, the frequency of microwave is 14GHz in the step (3).
Further, the revolving speed of Rotary Evaporators is 90rpm in the step (4), temperature when rotary evaporation in water-bath Degree is set as 82 DEG C.
Further, temperature control when dry in the step (5) in baking oven is 70 DEG C.
Comparative example 1
This comparative example 1 compared with Example 2, saves the ultrasonication in step (2) operation b, method step in addition to this It is rapid all the same.
Comparative example 2
This comparative example 2 compared with Example 2, saves the whole operation of step (2) operation b, and method and step in addition to this is equal It is identical.
Comparative example 3
Microwave heating in step (3) compared with Example 2, is melted into conventional heating water bath, in addition to this by this comparative example 3 Method and step it is all the same.
Control group
Commercially available common Traditional Chinese Drug Anticancer new drug granule.
In order to compare effect of the present invention, embodiment 2, comparative example 1, comparative example 2, comparative example 3 are used respectively Method preparation anti-cancer drugs granule and the anti-cancer drugs granule of control group carry out external inhibiting tumor assay, specific experiment It is:
(1) culture of tumour cell:
Human cervical carcinoma Hela cell's strain DMEM culture solution culture for containing 10% fetal calf serum is chosen, condition of culture is 3 DEG C, 5%CO2 Concentration and saturated humidity.When cell grows to logarithmic growth phase, with 25% trypsin digestion cell, dispels cell and be diluted to 106/ mL, every 100 μ L of hole are inoculated in 96 orifice plates, in case MTT experiment.
(2) cell proliferation experiment (mtt assay)
With the DMEM solution containing 10% fetal calf serum by embodiment 2, comparative example 1, comparative example 2, comparative example 3, right It is diluted to the solution that concentration is 25 μ g/mL according to the anti-cancer drugs granule of group, every 100 μ L of hole is inoculated in 96 orifice plates, is put into culture Case continues culture 16,32,48h.5 μ L of 5mg/mL MTT solution is added in every hole, continues to cultivate 5h, measures every hole absorbance.With not The culture cell for adding any processing is blank control.Each processing is respectively provided with 12 parallel groups, calculates separately cell inhibitory rate.
Specific experiment correlation data is as shown in table 1 below:
Table 1
Cultivate 16h inhibiting rate % Cultivate 32h inhibiting rate % Cultivate 48h inhibiting rate %
Embodiment 2 13±1.9 15±1.8 16±2.1
Comparative example 1 12±1.6 13±1.5 15±1.6
Comparative example 2 9±1.2 11±1.5 12±1.4
Comparative example 3 11±1.3 13±1.5 13±1.4
Control group 10±1.2 11±1.3 12±1.2
Note: inhibiting rate=1-(experimental group absorbance values/blank control group absorbance values described in upper table 1) × 100%。
The anti-cancer drugs granule that the present invention is finally prepared it can be seen from upper table 1, material matching is reasonable, biological utilisation Degree is high, the curative effect of the pre- anti-cancer having had and treating cancer, and materials safety, great market popularization value.

Claims (8)

1. a kind of preparation of anti-cancer drugs granule, which comprises the steps of:
(1) raw material weighs:
Weigh 2 ~ 4 parts of paris polyphylla, 2 ~ 4 parts of the uncaria, 4 ~ 6 parts of Fructus Forsythiae, 4 ~ 6 parts of oldenlandia diffusa, full worm 11 ~ 13 of corresponding parts by weight Part, 4 ~ 6 parts of curcuma zedoary, 2 ~ 4 parts recklessly purple, 3 ~ 5 parts of centipede, 2 ~ 3 parts of semen momordicae it is spare;
(2) pretreatment of raw material:
A. by weighed paris polyphylla, uncaria, Fructus Forsythiae, oldenlandia diffusa, full worm, curcuma zedoary, purple Hu, centipede, semen momordicae in step (1) It putting into deep cooling type pulverizer and is crushed respectively, it is -12 ~ -8 DEG C that the temperature in pulverizer is kept when crushing, pulverization process 20 ~ After 30min, 40 meshes are crossed respectively, then carry out each herb powder after sieving to mix to obtain mixed-powder;
B. it will operate and be impregnated in the investment enzyme solution of mixed-powder obtained in a, temperature when enzyme solution impregnates in holding enzyme solution is 39 ~ 43 DEG C, after 50 ~ 60min of enzyme solution immersion treatment, filter cake and filtrate are filtered to obtain, carries out specific frequency while enzyme solution impregnates Ultrasonication;
(3) extraction is handled:
Step (1) is operated gained filter cake in b to be placed in soxhlet extraction device, step (1) is operated into filtrate and nothing obtained in b Water-ethanol carries out mixing and extracts as digestion agent to filter cake, is heated in leaching process using microwave, and microwave heating is protected Holding the temperature in digestion agent is 88 ~ 94 DEG C, filters to obtain leaching liquor after extracting 10 ~ 12 times repeatedly;
(4) concentration:
Rotary evaporation will be carried out in the leaching liquor investment Rotary Evaporators obtained after extraction processing in step (3), rotary evaporation is straight Ethanol extract is obtained after to ethyl alcohol evaporating completely;
(5) drying and granulating:
Step (4) resulting ethanol extract is placed in baking oven and is dried, after drying to moisture content is 2 ~ 3%, after drying It is pelletized in ethanol extract investment granulator.
2. a kind of preparation of anti-cancer drugs granule according to claim 1, which is characterized in that in step (2) the operation b Each ingredient and corresponding parts by weight in enzyme solution are as follows: 2 ~ 3 parts of pectase, turns 1 ~ 2 part of glycosides enzyme, nanometer iron powder 3 ~ 4 at 4 ~ 5 parts of cellulase Part, 100 ~ 120 parts of deionized water.
3. a kind of preparation of anti-cancer drugs granule according to claim 1, which is characterized in that in step (2) the operation b The w/v of mixed-powder and enzyme solution is 1g:5 ~ 6mL.
4. a kind of preparation of anti-cancer drugs granule according to claim 1, which is characterized in that in step (2) the operation b The frequency of ultrasonic wave is 20 ~ 24kHz.
5. a kind of preparation of anti-cancer drugs granule according to claim 1, which is characterized in that filtrate in the step (3) Volume ratio with dehydrated alcohol is 1:3 ~ 4.
6. a kind of preparation of anti-cancer drugs granule according to claim 1, which is characterized in that microwave in the step (3) Frequency be 12 ~ 14GHz.
7. a kind of preparation of anti-cancer drugs granule according to claim 1, which is characterized in that rotation in the step (4) The revolving speed of evaporimeter is 80 ~ 90rpm, and temperature setting when rotary evaporation in water-bath is 80 ~ 82 DEG C.
8. a kind of preparation of anti-cancer drugs granule according to claim 1, which is characterized in that dry in the step (5) When baking oven in temperature control be 60 ~ 70 DEG C.
CN201811175823.2A 2018-10-10 2018-10-10 A kind of anti-cancer drugs granule and preparation method thereof Pending CN109091650A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811175823.2A CN109091650A (en) 2018-10-10 2018-10-10 A kind of anti-cancer drugs granule and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811175823.2A CN109091650A (en) 2018-10-10 2018-10-10 A kind of anti-cancer drugs granule and preparation method thereof

Publications (1)

Publication Number Publication Date
CN109091650A true CN109091650A (en) 2018-12-28

Family

ID=64868178

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811175823.2A Pending CN109091650A (en) 2018-10-10 2018-10-10 A kind of anti-cancer drugs granule and preparation method thereof

Country Status (1)

Country Link
CN (1) CN109091650A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102475822A (en) * 2010-11-27 2012-05-30 冯文明 Oral liquid capable of preventing and treating cervical cancer
CN104415290A (en) * 2013-08-26 2015-03-18 广东省中医院 Stagnation-removing decoction oral liquid and preparation method thereof
CN107335022A (en) * 2017-07-27 2017-11-10 冯敏杰 A kind of compound zedoary bark of eucommia anti-cervical cancer oral liquid and its preparation technology

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102475822A (en) * 2010-11-27 2012-05-30 冯文明 Oral liquid capable of preventing and treating cervical cancer
CN104415290A (en) * 2013-08-26 2015-03-18 广东省中医院 Stagnation-removing decoction oral liquid and preparation method thereof
CN107335022A (en) * 2017-07-27 2017-11-10 冯敏杰 A kind of compound zedoary bark of eucommia anti-cervical cancer oral liquid and its preparation technology

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
夏丽等: "《临床诊疗思维技巧》", 31 January 2010, 内蒙古科学技术出版社 *
杨明: "《中药药剂学》", 31 July 2016, 中国中医药出版社 *

Similar Documents

Publication Publication Date Title
CN102631377A (en) Cordyceps sinensis freeze-dried nano powder tablet and preparation method thereof
CN105147618A (en) Preparation method for Chinese herb decocting-free preparation containing heat-sensitive effective components
CN104887721A (en) Ultramicro decoction pieces made of Ganoderma lucidum pure powders, method for preparing ultramicro decoction pieces and application of ultramicro decoction pieces
CN102379949A (en) Preparation process of sini powder
CN106582985A (en) Ultramicro wall breaking and smashing method for rhizomatic traditional Chinese medicine
Hou et al. Salt processing: A unique and classic technology for Chinese medicine processing
CN102319357A (en) Lipid-lowering dispersible tablets and preparation technology thereof
CN105664018A (en) Cholagogue and lithagogue tablets and preparation method thereof
CN109091650A (en) A kind of anti-cancer drugs granule and preparation method thereof
CN103800448B (en) A kind of Balanophora dioica R Br ex Royle, Yunnan Radix Polygoni Multiflori Preparata pharmaceutical composition and preparation method thereof, preparation and application
CN106038828A (en) Callicarpa nudiflora extract containing rich verbascoside and preparation method of callicarpa nudiflora extract
CN105168407A (en) Preparation method of Xiaojin pills
CN104606519A (en) Novel preparation method of antelope cold preparation
CN102119966B (en) Preparation method of Chinese medicinal preparation for treating hepatitis disease by microwave-assisted extraction
CN100455300C (en) Compound wild kiwi tablet and its preparing method
CN1063953C (en) Medicine for treating kidney deficiency and preparation method thereof
CN103055062A (en) Granule infusion for heat clearing and dampness dispelling, and its preparation method
CN112402515A (en) Chinese medicinal extract containing insect medicine and preparation method of preparation thereof
CN100363027C (en) Liver-care composition and its prepn. method
CN1051708C (en) Chinese medicine for constipation and its preparation
CN115554364A (en) Traditional Chinese medicine and Tibetan medicine composition for preventing and treating diarrhea of yaks
CN110251585A (en) The Chinese medicine composition and its manufactured bagged instant preparation and preparation method of a kind of invigorating qi and benefiting blood
CN102743712A (en) Medicine composition for hepatitis
CN108295040A (en) Yuxintong capsules preparation method
CN105708873A (en) Chinese astilbe herb ultra-fine powder decoction pieces and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20181228

RJ01 Rejection of invention patent application after publication